DrugPatentWatch Database Preview
Arbor Pharms Llc Company Profile
What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has twenty-three approved drugs.
There are twenty-two US patents protecting ARBOR PHARMS LLC drugs.
There are three hundred and nine patent family members on ARBOR PHARMS LLC drugs in forty-six countries and thirty supplementary protection certificates in sixteen countries.
Summary for Arbor Pharms Llc
| International Patents: | 309 |
| US Patents: | 22 |
| Tradenames: | 24 |
| Ingredients: | 15 |
| NDAs: | 23 |
Drugs and US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | ERYTHROMYCIN | erythromycin | TABLET;ORAL | 061621-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Arbor Pharms Llc | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | TABLET;ORAL | 061904-001 | Approved Prior to Jan 1, 1982 | BX | RX | No | Yes | Start Trial | Start Trial | ||||
| Arbor Pharms Llc | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | 8,026,279 | Start Trial | Y | Y | Start Trial | ||
| Arbor Pharms Llc | ERYTHROCIN STEARATE | erythromycin stearate | TABLET;ORAL | 060359-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Arbor Pharms Llc | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | 10,166,181 | Start Trial | Y | Start Trial | |||
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | RX | Yes | No | 9,066,936 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | 5,583,141 | Start Trial |
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | 5,583,141 | Start Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 4,757,128 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-001 | Feb 25, 2011 | 5,958,961 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | 5,736,555 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | 5,958,961 | Start Trial |
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-002 | Dec 20, 2011 | 5,583,141 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 554737 | Start Trial |
| South Korea | 100926921 | Start Trial |
| Japan | 2007508396 | Start Trial |
| Japan | 2004536873 | Start Trial |
| European Patent Office | 2653160 | Start Trial |
| China | 101434572 | Start Trial |
| South Korea | 20060106815 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1718641 | CA 2012 00013 | Denmark | Start Trial | |
| 1718641 | PA2012004 | Lithuania | Start Trial | PRODUCT NAME: AZILSARTANUM MEDOXOMILUM; REGISTRATION NO/DATE: EU/1/11/734/001 - EU/1/11/734/011, 2011 12 07, EU/1/11/735/001 - EU/1/11/735/011 20111207 |
| 1620113 | 300756 | Netherlands | Start Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN DE BEHANDELING VAN ROSACEA; FIRST REGISTRATION NO/DATE: MA117/01101 20150402; NATIONAL REGISTRATION NO/DATE: RVG 115310 20150504 |
| 1620113 | PA2015033 | Lithuania | Start Trial | PRODUCT NAME: IVERMECTINUM; NAT. REGISTRATION NO/DATE: LT/1/15/3726/001 - LT/1/15/3726/005 20150513; FIRST REGISTRATION: MA117/01101 20150402 |
| 1620113 | C 2015 036 | Romania | Start Trial | PRODUCT NAME: IVERMECTINA; NATIONAL AUTHORISATION NUMBER: RO7674/2015/01, RO7674/2015/02, RO7674/2015/03, RO7674/2015/04, RO7674/2015/05; DATE OF NATIONAL AUTHORISATION: 20150526; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MALTA MA117/01101; DATE OF FIRST AUTHORISATION IN EEA: 20150402 |
| 1718641 | C20120005 00053 | Estonia | Start Trial | PRODUCT NAME: IPREZIV - ASILSARTAANMEDOKSOMIIL;REG NO/DATE: C(2011) 9281 FINAL 07.12.2011 |
| 1620113 | 92915 | Luxembourg | Start Trial | PRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
